Mabcure Inc (MBCI)

$0.00 0.00 (N/A)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 400
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 50%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan. MabCure Inc...

Industry: Solar
Sector: Technology
Phone: 845 591 3144
Address:
21 Sparrow Circle, White Plains, United States
Latest News on MBCI
No data available.